Cardiovascular risks post-COVID-19 vaccination: Key findings

FHS
October 3, 2024
10:29 am

Researchers explore the risks of cardiovascular and cerebrovascular events following vaccination against the COVID-19.

Argenx scraps program in skin autoimmune disease after Vyvgart Hytrulo flunks another PhIII trial

Argenx’s autoimmune disease drug Vyvgart Hytrulo flunked its second late-stage trial in as many months, and the company is abandoning the indication altogether. The Dutch

December 21, 2023

Topical immunotherapy clears precancerous skin lesions and reduces cancer risk

Calcipotriol-plus–5-FU therapy activates immune pathways, offering long-lasting protection against squamous cell carcinoma by targeting precancerous lesions.

January 6, 2025

Mexican American women show highest rates of medication nonadherence after stroke

Women who have had a stroke may be less likely than men to take medications to prevent a second stroke, with Mexican American women reporting

December 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.